Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia

References

• Lee RC, Feinbaum RL, Ambros V, et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854. doi: 10.1016/0092-8674(93)90529-Y
   PubMed Web of Science ®Google Scholar
• Yin Y, Jun L, Shujie C, et al. MicroRNAs as diagnostic biomarkers in gastric cancer. Int J Mol Sci. 2012;13:12544–12555. doi: 10.3390/ijms131012544
   PubMed Web of Science ®Google Scholar
• Li Q, Liu L, Li W. Identification of circulating microRNAs as biomarkers in diagnosis of hematologic cancers: a meta-analysis. Tumor Biol. 2014;35:10467–10478. doi: 10.1007/s13277-014-2364-4
   PubMed Web of Science ®Google Scholar
• Godfrey A, Zongli X, Clarice R, et al. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 2013;15:350–351. doi: 10.1186/bcr3428
   Web of Science ®Google Scholar
• Oorschot D, Kuipers E, Arentsen-Peters S, et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2012;58:715–721. doi: 10.1002/pbc.23279
   PubMed Web of Science ®Google Scholar
• de Oliveira C, Scrideli A, Brassesco S, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leuk Res. 2012;36:293–298. doi: 10.1016/j.leukres.2011.10.005
   PubMed Web of Science ®Google Scholar
• Suhag V, Solomon S, Malkovska V. Acute myelogenous leukemia. In: Rodgers P, Young N, editors. Bethesda handbook of clinical hematology. New York: Lippincott Williams & Wilkins; 2005. p. 131–147.
   Google Scholar
• Si H, Xiaoming S, Yingjian C, et al. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol. 2013;139:223–229. doi: 10.1007/s00432-012-1315-y
   PubMed Web of Science ®Google Scholar
• Bassan R, Gatta G, Tondini C, et al. Adult acute lymphoblastic leukaemia. Crit Rev Oncol Hematol. 2004;50:223–261. doi: 10.1016/j.critrevonc.2003.11.003
   PubMed Web of Science ®Google Scholar
• Heneghan H, Miller N, Lowery A, et al. Circulatory microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010;251(3):499–505. doi: 10.1097/SLA.0b013e3181cc939f
   PubMed Web of Science ®Google Scholar
• Friedmann AM, Weinstein HJ. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist. 2000;5(4):321–328. doi: 10.1634/theoncologist.5-4-321
   PubMedGoogle Scholar
• Han W, Feng D, Li G, et al. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet. 2011;20(24):4903–4915. doi: 10.1093/hmg/ddr428
   PubMed Web of Science ®Google Scholar
• Li P, Wang X. Role of signaling pathways and miRNAs in chronic lymphocytic leukemia. Chin Med J (Engl). 2013;126(21):4175–4182.
   PubMed Web of Science ®Google Scholar
• Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67:129–139. doi: 10.1007/s13105-010-0050-6
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866. doi: 10.1038/nrc1997
   PubMed Web of Science ®Google Scholar
• Ali S, Khaldoun A, Wei C, et al. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res. 2011;3(1):28–47.
   Web of Science ®Google Scholar
• Zhao H, Jie S, Leonard M, et al. A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One. 2010;5(10):e13735. DOI:10.1371/journal.pone.0013735
   PubMed Web of Science ®Google Scholar
• Zeng Z, Wang J, Zhao L, et al. Potential role of microRNA-21 in the diagnosis of gastric cancer: a meta-analysis. PLoS One. 2013;8(9):e73278. DOI:10.1371/journal.pone.0073278
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin1 (TPM1). J BiolChem. 2007;282:14328–14336.
   PubMed Web of Science ®Google Scholar
• Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein. Int J Mol Med. 2010;26:819–827. doi: 10.3892/ijmm_00000530
   PubMed Web of Science ®Google Scholar
• Sontheimer EJ. Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol. 2005;6:127–138. doi: 10.1038/nrm1568
   PubMed Web of Science ®Google Scholar
• Kohanbash G, Okada H. MicroRNAs and STAT interplay. Semin Cancer Biol. 2012;22:70–75. doi: 10.1016/j.semcancer.2011.12.010
   PubMed Web of Science ®Google Scholar
• Carraro G, El Hashash A, Guidolin D, et al. MiR 17 family of microRNAs controls FGF10 mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E Cadherin distribution. Dev Biol. 2009;333:238–250. doi: 10.1016/j.ydbio.2009.06.020
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Ludmila W, Anne L, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;2011:1–11.
   Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011;108:5003–5008. doi: 10.1073/pnas.1019055108
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–433. doi: 10.1038/ncb2210
   PubMed Web of Science ®Google Scholar
• Hasselmann DO, Rappl G, Tilgen W, et al. Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem. 2001;147:1488–1489.
   Google Scholar
• Kishore A, Jana B, Jana P, et al. Review article novel insights into miRNA in lung and heart inflammatory diseases. Mediat Inflamm. 2014;2014:27. doi: 10.1155/2014/259131
   Web of Science ®Google Scholar
• Tokarz P, Blasiak J. The role of microRNA in metastatic colorectalcancer and its significance in cancer prognosis andtreatment. Acta Biochim Pol. 2012;59(4):467–474.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Tsujiura M, et al. Prognostic impact of circulating miR-21 in the plasmaof patients with gastric carcinoma. Anticancer Res. 2013;33(1):271–276.
   PubMed Web of Science ®Google Scholar
• Lawrie C, Gal S, Dunlop H, et al. Detection of elevated levels of tumor-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141(5):672–675. doi: 10.1111/j.1365-2141.2008.07077.x
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121:1156–1161. doi: 10.1002/ijc.22800
   PubMed Web of Science ®Google Scholar
• Mao X, Sun Y, Tang J. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma. Neurol Sci. 2014;35:233–238. doi: 10.1007/s10072-013-1491-9
   PubMed Web of Science ®Google Scholar